<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02802176</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 166094</org_study_id>
    <nct_id>NCT02802176</nct_id>
  </id_info>
  <brief_title>Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation</brief_title>
  <official_title>Randomized Controlled Trial Comparing Intra-vaginal Culture of Embryos Using INVOcell Device to In-vitro Culture of Embryos Using Minimal Stimulation Protocols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate implantation rate with intra-vaginal culture (IVC)
      with the INVOcell device versus traditional In-Vitro Fertilization (IVF) while using minimal
      stimulation protocols
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase IV, single center randomized controlled trial evaluating intra-vaginal
      culture (IVC) using INVOcell versus traditional In-Vitro Fertilization (IVF) using oral
      stimulation or minimal gonadotropin stimulation protocols. The pilot aims to includes 40
      women who will be randomized to either the intra-vaginal culture group (N=20) using INVOcell
      or to the traditional IVF group (N=20).

      Primary aim is implantation rate, which is defined by number gestational sacs seen on early
      pregnancy ultrasound divided by number of embryos transferred.

      Secondary aims are:

        -  Embryo quality, which is measured by the Gardner grading system.

        -  Fertilization rate, which is defined by the total number of fertilized oocytes divided
           by total number of mature oocytes retrieved. This comparison will take place on day-3,
           as that is when the IVC embryos will be assessed.

        -  Clinical pregnancy rate, which is defined by the number of fetal poles with heartbeat
           seen on ultrasound divided by the number of embryos transferred.

        -  Live birth rate, which is defined by the number of living babies delivered divided by
           the number of transfers
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Arm 1: intra-vaginal culture using INVOcell device. Arm 2: Traditional In-Vitro Fertilization (IVF) culture in an embryology laboratory</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>approximately 4 weeks following randomization</time_frame>
    <description>defined by number gestational sacs seen on early pregnancy 6-week ultrasound divided by number of embryos transferred</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryo quality</measure>
    <time_frame>measured after 3 days of incubation</time_frame>
    <description>quality determined using Gardner grading system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>measured after 3 days of incubation</time_frame>
    <description>defined by the total number of fertilized oocytes divided by total number of mature oocytes retrieved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>approximately 4 weeks following randomization</time_frame>
    <description>which is defined by the number of fetal poles with heartbeat seen on 6-week ultrasound divided by the number of embryos transferred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>9 months after embryo transfer</time_frame>
    <description>which is defined by the number of living babies delivered divided by the number of transfers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Intra-vaginal culture - INVOcell device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 day intra-vaginal incubation using the INVOcell device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional IVF culture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 day traditional IVF incubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>INVOcell device</intervention_name>
    <description>intra-vaginal culture of embryos using INVOcell device</description>
    <arm_group_label>Intra-vaginal culture - INVOcell device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional IVF</intervention_name>
    <description>traditional culture of embryos in-vitro</description>
    <arm_group_label>Traditional IVF culture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal uterine cavity

          -  One or more years of infertility

          -  Normal male partner semen analysis

        Exclusion Criteria:

          -  Age &lt;18 years old or &gt;37 years old

          -  Antral Follicle Count (AFC) &lt;8

          -  Abnormal male partner semen analysis or use of donor sperm

          -  Vaginal inflammation or genital (vaginal, uterine, tubal) infection

          -  Uncontrolled chronic disease (such as uncontrolled diabetes or hypertension)

          -  Uterine anatomic abnormalities

          -  Allergy to plastics or inability to use diaphragm retention device

          -  Untreated hydrosalpinx

          -  Current alcohol abuse (defined by &gt;14 drinks/week)

          -  Prior history of IVF cycle where fertilization did not occur

          -  History of recurrent pregnancy loss
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelle Cedars, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Asima K Ahmad, MD, MPH</last_name>
    <phone>4153537475</phone>
    <email>asima.ahmad@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcelle Cedars, MD</last_name>
    <phone>4153537475</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California San Francisco - Center for Reproductive Health</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asima K Ahmad, MD, MPH</last_name>
      <phone>415-353-7475</phone>
      <email>crh.research@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nikolaus Lenhart</last_name>
      <phone>4153537475</phone>
      <email>nikolaus.lenhart@ucsf.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.invobioscience.com/</url>
    <description>INVOcell device</description>
  </link>
  <link>
    <url>http://ivf.ucsf.edu/ivf/</url>
    <description>University of California San Francisco Center for Reproductive Health</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 12, 2016</study_first_submitted>
  <study_first_submitted_qc>June 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2016</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

